Curcumin restores mitochondrial functions and decreases lipid peroxidation in liver and kidneys of diabetic db/db mice by María G Soto-Urquieta et al.
Soto-Urquieta et al. Biological Research 2014, 47:74
http://www.biolres.com/content/47/1/74RESEARCH ARTICLE Open AccessCurcumin restores mitochondrial functions and
decreases lipid peroxidation in liver and kidneys of
diabetic db/db mice
María G Soto-Urquieta1, Sergio López-Briones1, Victoriano Pérez-Vázquez1, Alfredo Saavedra-Molina2,3,
Gloria A González-Hernández4 and Joel Ramírez-Emiliano1*Abstract
Background: Nitrosative and oxidative stress play a key role in obesity and diabetes-related mitochondrial dysfunction.
The objective was to investigate the effect of curcumin treatment on state 3 and 4 oxygen consumption, nitric oxide
(NO) synthesis, ATPase activity and lipid oxidation in mitochondria isolated from liver and kidneys of diabetic db/db mice.
Results: Hyperglycaemia increased oxygen consumption and decreased NO synthesis in liver mitochondria isolated
from diabetic mice relative to the control mice. In kidney mitochondria, hyperglycaemia increased state 3 oxygen
consumption and thiobarbituric acid-reactive substances (TBARS) levels in diabetic mice relative to control mice.
Interestingly, treating db/db mice with curcumin improved or restored these parameters to normal levels; also curcumin
increased liver mitochondrial ATPase activity in db/db mice relative to untreated db/db mice.
Conclusions: These findings suggest that hyperglycaemia modifies oxygen consumption rate, NO synthesis and
increases TBARS levels in mitochondria from the liver and kidneys of diabetic mice, whereas curcumin may have a
protective role against these alterations.
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Obesity and diabetes are serious and growing public
health problems that result in reduced life expectancy
and increased morbidity due to disease-specific vascular
complications. Moreover, there is considerable evidence
linking obesity and diabetes with oxidative stress and
mitochondrial dysfunction in human and animal models.
For instance, serum thiobarbituric acid-reactive substances
(TBARS) were elevated, and serum total thiols and super-
oxide dismutase (SOD) activity were decreased in patients
with metabolic syndrome compared with healthy subjects
[1]. Likely, systemic oxidative stress was increased in obese
children with and without metabolic syndrome [2], and re-
active oxygen species (ROS) and malondialdehyde (MDA)
were higher in diabetic subjects compared with control
subjects [3]. With respect to adenosine-5′-triphosphate* Correspondence: joelre@ugto.mx
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unless otherwise stated.(ATP) synthesis, abdominal obesity was associated with
reduced mitochondrial ATP and ROS production rates in
skeletal muscle of men [4]. Moreover, diabetic patients
had reduced ATP synthesis and elevated lipid contents in
liver [5], as well as reduced ATP synthesis [6,7]; and
reduced expression of the α-subunit of ATP synthase [8]
in skeletal muscle as compared to control subjects.
Mitochondria isolated from the livers of mice that
were fed a high-fat diet (HFD) exhibit decreased state 3
respiration, decreased uncoupled respiration, and alter-
ations in cytochrome c oxidase activity and mitochondrial
membrane potential [9]. In the HFD-fed mice, there was
accumulation of 3-nitrotyrosine and increased sensitivity
to nitric oxide (NO)-dependent respiratory inhibition
compared with non-obese controls.
To reduce oxidative stress caused by obesity and dia-
betes, dietary supplementation of antioxidants has been
proposed. Different studies have shown that curcumin has
antioxidant and anti-hyperglycaemic properties in diabetic
and obese animal models [10-13]. It was reported that theentral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Effect of hyperglycaemia and curcumin on the gain of
body weight. Mice were weighted every three days for one month.
Wild type mice (n = 4); Untreated-diabetic mice (n = 4); Treated-diabetic
mice (n = 9). Data are given as the means ± standard error of the
mean (SEM).
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dismutase and catalase were significantly higher (2- and
1.5-fold, respectively), and glutathione peroxidase activity
was significantly lower (0.7 fold) in diabetic db/db mice
than in nondiabetic db/+ mice. In the db/db mice, these
enzyme activities were restored to basal values after curcu-
min treatment. Curcumin also significantly decreased
MDA levels from 479.7 to 393.3 nmol/g haemoglobin in
erythrocytes of these mice [12]. Furthermore, in PC12
cells that were exposed to 4-hydroxynonenal, curcumin
treatment prevented changes in glutathione levels as well
as mitochondrial oxidative damage and respiration and
decreased the accumulation of carbonylated proteins and
apoptosis [14].
We recently showed that curcumin treatment increased
oxygen consumption and significantly decreased lipid and
protein oxidation levels in liver mitochondria isolated
from HFD-induced obese mice compared with those in
the untreated obese mice [15]. In kidney mitochondria,
curcumin treatment significantly increased oxygen con-
sumption and decreased lipid and protein peroxidation
levels in HFD-induced obese mice when compared with
those in untreated obese mice. Curcumin treatment neither
had any effect on body weight gain or on mitochondrial
NO synthesis.
Therefore, we testing hypotheses of that dietary sup-
plementation with curcumin improve indices of lipid
oxidation, oxygen consumption rate, nitric oxide (NO)
synthesis and ATPase activity in the liver and kidneys of
diabetic db/db mice.
Results
Curcumin decreases body weight in db/db mice
To examine the effect of curcumin on the gain of body
weight, the mice were weighted at the beginning of the
curcumin treatment and no significant differences were
observed between the untreated diabetic and curcumin-
treated diabetic mice (35.3 ± 0.9 and 35.6 ± 0.5 g, respect-
ively), both groups of diabetic mice were significantly
heavier than wild type mice (Figure 1). At the end of the
treatment, curcumin treatment significantly decreased the
gain of body weight of the diabetic mice (52 ± 0.9 g) com-
pared with diabetic mice that were not treated (60 ± 1.6 g).
The diabetic mice, whether treated with curcumin or
untreated, were significantly heavier than the wild type
mice (29 ± 0.8 g).
Curcumin decreases blood glucose levels in db/db mice
In untreated diabetic mice, blood glucose levels were
higher than in the wild type mice (488.2 ± 73 vs. 152 ±
11 mg/ml, p < 0.01). Curcumin treatment decreased
blood glucose levels in diabetic mice (196.3 ± 13 mg/ml)
as compared to untreated diabetic mice (p < 0.01), but
these levels were higher than in wild type mice (p < 0.05).With respect to blood cholesterol levels, these were higher
in untreated diabetic mice than in the wild type mice
(207 ± 35 vs. 156.5 ± 4.3 mg/ml, p < 0.05); whereas cur-
cumin treatment decreased blood cholesterol levels in
diabetic mice (161.4 ± 4 mg/ml) as compared to untreated
diabetic mice (p < 0.05). There were no significant differ-
ences on blood levels triglycerides among wild-type,
untreated diabetic and curcumin-treated diabetic mice
(227.7 ± 40.3, 297 ± 59 and 344.8 ± 27 mg/ml, respectively).
Curcumin couples oxygen consumption
In liver mitochondria, state 3 respiration was similar
between the diabetic untreated and curcumin-treated
mice (40 ± 4.1 and 40 ± 5.2 nmoles O2/mg prot · min,
respectively). There was a 66% increase in state 3 mito-
chondrial oxygen consumption in diabetic untreated and
curcumin-treated mouse liver mitochondria compared to
mitochondria derived from wt livers (24 ± 5.3 nmoles O2/
mg prot · min) (Figure 2A). In mitochondria that were
isolated from the diabetic untreated mouse livers, state 4
oxygen consumption was increased from 3.8 ± 0.9 to 9.4 ±
2.4 nmoles O2/mg prot · min, compared with mitochon-
dria from the wt mouse livers, whereas state 4 respiration
was 5 ± 0.9 nmoles O2/mg prot · min in mitochondria
from the curcumin-treated mouse livers (Figure 2B); no
differences were observed between diabetic curcumin-
treated and wt mice. Furthermore, in curcumin-treated
diabetic mice, state 4 oxygen consumption was decreased
by 47% as compared with untreated diabetic mice.
The kidney was chosen because is one of the most fre-
quently and severely affected organs. In addition, kidney
is an insulin-independent organ in which glucose uptake
is facilitated by the SGLT2 transporter, a protein that is
abundant in the kidney compared to the liver [16]. As
expected, in kidney mitochondria isolated from untreated
Figure 2 Effect of hyperglycaemia and curcumin on mitochondrial respiration rate in state 3 (A) and state 4 (B). Black bars, wild type mice
(WTM, n = 4); empty bars, untreated-diabetic mice (UDM, n = 4); gray bars, treated-diabetic mice (TDM, n = 9). Data are given as the means ± standard
error of the mean (SEM). *p < 0.05 vs. WTM; **p < 0.05 vs. UDM.
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creased 3-fold compared with wt mice (75 ± 19.4 vs. 24 ±
3.5 nmoles O2/mg prot · min). In kidney mitochondria,
curcumin treatment of the diabetic mice decreased state 3
oxygen consumption rates (25 ± 7.4 nmoles O2/mg prot ·
min) to levels that were similar to those obtained from the
wild type mice (Figure 2A). In kidney mitochondria from
untreated diabetic mice, state 4 oxygen consumption was
two-fold higher compared with wt mice (11.5 ± 1.4 and
6.1 ± 1.6 nmoles O2/mg prot · min, respectively); whereas
in kidney mitochondria isolated from diabetic mice,
curcumin treatment restored state 4 oxygen consumption
(5 ± 1.9 nmoles O2/mg prot · min) to levels similar to
mitochondria isolated from wt mouse kidneys (Figure 2B).
Together, these results clearly demonstrate that the
curcumin treatment decreased state 3 and 4 oxygen con-
sumption in kidney mitochondria and only state 4 in liver.
Curcumin increases ATPase activity in liver mitochondria
Curcumin treatment decreased oxygen consumption in
the liver and kidney; therefore we evaluated the effect of
this polyphenol on ATPase activity. ATPase activity is anindirect measurement of the capacity that the mito-
chondria have to synthesis ATP. In liver mitochondria
from untreated diabetic mice, ATPase activity was non-
significantly reduced from 2.8 ± 0.24 to 2.05 ± 0.65 nmoles
Pi/mg prot · min compared with liver mitochondria from
wt mice, whereas curcumin treatment non-significantly
increased liver mitochondria ATPase activity by 152%
(4.2 ± 0.41 nmoles Pi/mg prot · min) compared with wt
mice (Figure 3). Curcumin-treated diabetic mice had
significantly higher liver mitochondria ATPase activity
than untreated diabetic mice. Kidney mitochondrial
ATPase activity was not significantly affected by hypergly-
caemia or curcumin; thus, ATPase activity was similar
between curcumin-treated diabetic, untreated diabetic and
wild type mice (5.8 ± 0.17, 5.3 ± 0.23 and 6.0 ± 0.2 nmoles
Pi/mg prot·min) (Figure 3).
Curcumin restores nitric oxide synthesis in liver
mitochondria
Mitochondrial NO regulates synthesis of ATP [17,18] and
is altered in diabetes [19]. Therefore, we determined the
effect of curcumin on the synthesis of mitochondrial NO
Figure 3 Effect of hyperglycaemia and curcumin on mitochondrial ATPase activity. Black bars, wild type mice (WTM, n = 4); empty bars,
untreated-diabetic mice (UDM, n = 4); gray bars, treated-diabetic mice (TDM, n = 9). Data are given as the means ± standard error of the mean
(SEM). **p < 0.05 vs. UDM.
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chondria from untreated diabetic mice compared with wt
mice mitochondria (0.63 ± 0.1 vs. 2.17 ± 0.37 nmoles/mg
prot · min, respectively) (Figure 4); however, in the treated
diabetic mice, NO synthesis in liver mitochondria was
only reduced by 21% (1.71 ± 0.31 nmoles/mg prot · min)
compared with wt mice and was higher than in the
untreated diabetic mice.
Kidney mitochondrial NO synthesis was non-significantly
affected by diabetes or curcumin; thus, the values were
0.5 ± 0.1, 0.33 ± 0.05 and 0.28 ± 0.03 nmoles/mg prot · min
in untreated diabetic, treated diabetic and wt mice,
respectively (Figure 4).
Curcumin decreases lipid peroxidation in liver and kidney
mitochondria
Figure 5 shows that in liver mitochondria isolated from
the untreated diabetic mice, TBARS values were non-
significantly higher than the wt mice (1.6 ± 0.35 and
1.27 ± 0.15 nmoles/mg protein, respectively), whereasFigure 4 Effect of hyperglycaemia and curcumin on mitochondrial nit
bars, untreated-diabetic mice (UDM, n = 4); gray bars, treated-diabetic mice
mean (SEM). *p < 0.05 vs. WTM; **p < 0.05 vs. UDM.curcumin treatment significantly decreased TBARS values
(0.86 ± 0.1 nmoles/mg protein) in mitochondria from the
diabetic mice compared with the wt and untreated-
diabetic mice.
In kidney mitochondria, TBARS levels significantly
increased in the untreated diabetic mice compared with
the wt mice (1.7 ± 0.16 vs. 0.80 ± 0.2 nmoles/mg protein,
respectively); however, in the curcumin-treated diabetic
mice, TBARS levels were non-significantly higher than
(0.93 ± 0.2 nmoles/mg protein) in the wt mice, and were
significantly lower than in the untreated diabetic mice.
Discussion
The db/db mouse model develop hyperphagic obesity and
nonketotic diabetes similar to non-insulin-dependent dia-
betes mellitus in humans. Diabetic features in db/db mice
follow an age-dependent progression, with early insulin
resistance followed by an insulin secretory defect resulting
in profound hyperglycemia. Thus, db/db mouse model
has provided a useful resource to understand and treat theric oxide synthesis. Black bars, wild type mice (WTM, n = 4); empty
(TDM, n = 9). Data are given as the means ± standard error of the
Figure 5 Effect of hyperglycaemia and curcumin on TBARS levels. Black bars, wild type mice (WTM, n = 4); empty bars, untreated-diabetic
mice (UDM, n = 4); gray bars, treated-diabetic mice (TDM, n = 9). Data are given as the means ± standard error of the mean (SEM). *p < 0.05 vs.
WTM; **p < 0.05 vs. UDM.
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study, diabetic db/db mice were using as diabetes model.
The present results demonstrate that curcumin treat-
ment significantly decreased body weight in db/db mice.
It was reported that curcumin decreases body weight by
reducing body fat and increasing lean mass in both
high-fat-diet-induced obese and ob/ob mice [20].
Using mitochondria isolated from untreated db/db
mice, we demonstrated that hyperglycaemia increases mito-
chondrial oxygen consumption in the liver and kidneys,
compared with non-diabetic wild type mice (Figure 2). This
finding contrasts with previous observation of mitochon-
drial dysfunction in liver from these same mice, which was
characterized by a reduced respiratory capacity [21]. How-
ever, another study, db/db hearts exhibited reduced cardiac
function and increased myocardial oxygen consumption;
whereas mitochondrial ROS generation and lipid and
protein peroxidation products were increased [22].
Thus, heart mitochondria from db/db mice exhibited
fatty acid–induced mitochondrial uncoupling and increased
expression of fatty acid oxidation genes and electron trans-
fer flavoproteins, whereas the content of the F1 α-subunit
of ATP synthase was reduced.
In kidney mitochondria from diabetic mice, curcumin
treatment decreased state 3 and 4 oxygen consumption
to levels that were similar to that in mitochondria from
wild type mice (Figure 2). With respect to liver mito-
chondria, curcumin treatment only decreased the state 4
oxygen consumption to levels that were similar to that
in mitochondria from wild type mice. It is important to
consider that glucose uptake in the kidney mainly uses
Glut1 transporter and that aerobic oxidation of glucose
is the predominant pathway in the kidney; consequently,
more redox equivalents are produced in the kidney [23].
We observed that ATPase activity was non-significantly
lower in mitochondria from the liver and kidneys of the
untreated diabetic mice, whereas treatment of theseanimals with curcumin significantly increased ATPase
activity in the liver but not in the kidneys (Figure 3).
Previous studies support that hyperglycaemia decreases
ATP synthesis by causing changes in oxygen consumption
both in humans and in rodents. For instance, obese and
diabetic subjects have a low amount of mitochondrial
and reduced capacity for mitochondrial ATP production
in skeletal muscle [24-28]. Furthermore, hyperglycaemia
decreased functions such as state 3 respiration, electron
transport chain activity, ATP synthase activity, mitochon-
drial membrane potential, ROS production and oxidative
damage in the heart of db/db mice [29,30]. Thus, there is
sufficient evidence that obesity and diabetes induce
deficiencies in ATP synthesis [4-8,24-28]. Therefore, the
beneficial effect of curcumin treatment on mitochondrial
functions suggests that this polyphenol could improve
ATP production in the diabetic mouse liver (Figure 3),
curcumin also decreases TBARS levels, suggesting that
curcumin could reduce the free radicals production or
remove these prooxidant molecules. Together, the present
results suggest that curcumin increases the ratio of ATP
production/oxygen consumption. However, in the present
study, we did determine ATPase activity instead of ATP
synthesis; for this reason, it is desirable to determine
whether curcumin can increase ATP synthesis in vivo.
It has been reported that NO regulates oxygen con-
sumption and consequently ATP production [17,18]. Our
results show that hyperglycaemia decreased NO synthesis
in liver and weakly increased this synthesis in kidneys,
whereas curcumin restored NO synthesis in both tissues
(Figure 4). It is probable that curcumin restores NO
synthesis and ATPase activity in liver by preventing the
oxidation of the enzymes nitric oxide synthase (NOS) and
ATPase or by inducing the expression of these enzymes.
Thus, curcumin treatment of db/db mice restored NO
synthesis and ATPase activity to wild type levels and
also decreased oxygen consumption and lipid oxidation.
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good alternative to restore the altered mitochondrial NO
production that is induced by hyperglycaemia in humans.
Because curcumin treatment restored oxygen consump-
tion, ATPase activity and NO production, we evaluated
whether treatment with this polyphenol reduced lipid
peroxidation. We observed that diabetic mice had in-
creased mitochondrial TBARS levels that were amelio-
rated by curcumin treatment both in the liver and in the
kidneys (Figure 5). The liver has been demonstrated to
have a higher oxidative metabolic rate than the kidneys
and to also have increased levels of TBARS [31], which
correlated with our results (Figure 5).
Taken together our results suggest that curcumin
improves the rate of oxygen consumption as well as
ATPase activity probably by scavenging free radicals and
preventing protein and lipid oxidation. Given that cen-
tral role for mitochondria is fuel utilisation and energy
production, dysfunctional mitochondria, as are found in
obesity and diabetes, can impact whole-body metabolic
homeostasis. Mitochondrial uncoupling may be elevated
in obesity due to increased FFA concentrations, which
may result in the development of diabetes mellitus and/
or other metabolic diseases [32,33]. However, although
the association between impaired mitochondrial function
and diabetes mellitus is strong, a causal pathogenic
relationship remains uncertain. For these reasons, the
results presented in this study are important to suggest
that hyperglycaemia induces mitochondrial dysfunction,
whereas curcumin treatment reverts the lipid oxidation
and mitochondrial dysfunction in the liver and kidney of
db/db mice that is caused by hyperglycaemia. Our data
are consistent with those reported previously in which
administration of Resveratrol to db/db mice normalised
mitochondrial function and biogenesis [34]. Moreover,
curcumin protected brain mitochondria by direct detoxi-
fication as well as prevention of 3-nitrotyrosine forma-
tion in a mouse model of Parkinson’s disease [35,36].
Conclusions
Our findings suggest that in db/db mice, dietary supple-
mentation with curcumin diminished mitochondrial dys-
function, likely by decreasing lipid peroxidation, which
results in an increase of ATPase activity, restoration of
oxygen consumption and NO synthesis in mitochondria
isolated from the liver and kidneys of db/db mice. To-
gether, these findings suggest that curcumin could be a
good alternative to prevent or decrease nitrosative and
oxidative stress as well as mitochondrial dysfunction
during obesity and diabetes. Therefore, more research is
necessary to elucidate whether curcumin may be effect-
ive for prevention and/or treatment of oxidative stress
and mitochondrial dysfunction in obese and diabetes
humans.Methods
Animal use and care
Female and male heterozygote non-diabetic db/+ mice
(BKS.Cg-m +/+ Leprdb/OlaHsd; Black, Lean) were pur-
chased from Harlan Laboratories (Mexico, DF) and were
back-crossed to start our colony. All mice had access to
water and food (Harlan Laboratories; Cat. No. T.2018S.15)
ad libitum. All animal procedures were performed in
accordance with current Mexican legislation (NOM-062-
ZOO-1999) and the National Institutes of Health (NIH,
Bethesda, MD) Guide for the Care and Use of Laboratory
Animals.
Mouse genotypes and curcumin treatment
The mouse genotyping was performed as previously
reported with some modifications [37-39]. Briefly, 1 mm
of ear tissue was digested in 100 μl lysis buffer [100 mM
Tris HCl (pH 8.5), 5 mM EDTA, 0.2% SDS, 200 mM
NaCl, and 4 μg proteinase K/ml] overnight at 65°C with
agitation, followed by incubation at 95°C for 10 min.
Then 100 μl 7.5 M ammonium acetate (pH 2) was added
to the lysate prior to centrifugation at 12,000 g for
15 min. The supernatant was recovered and mixed with
300 μl isopropanol followed by centrifugation at 12,000 g
for 15 min. The precipitated DNA was washed with
500 μl ethanol, followed by centrifugation at 12,000 g for
15 min. Finally, the DNA was dissolved in 25 μl of water,
and 1 μl of the DNA was used as the template for a
12.5 μl PCR reaction with the PCR master kit following
the manufacturer’s instructions (ROCHE, Mannheim,
Germany). Each primers was used at a concentration of
0.2 μM (forward, 5′-ATGACCACTACAGATGAACC
CAGTCTAC-3′; reverse, 5′-CATTCAAACCATAGTT
TAGGTTTGTCT-3′), as was previously reported [37-39].
The PCR conditions were as follows: an initial denatur-
ation of 3 min at 95°C followed by 5 cycles of 95°C for
1 min, 60°C for 1 min, and 72°C for 30 sec; then 30 cycles
of 92°C for 15 sec, 50°C for 1 min, and 72°C for 30 sec.
Ten microliters of the PCR reaction was digested with the
restriction enzyme AccI according to the manufacturer’s
instructions (New England Biolabs, Inc.), followed by elec-
trophoresis on a 15% polyacrylamide gel. Digestion with
AccI yielded 85- and 24-bp fragments in the wild type
(+/+) mice, 85-, 58-, 27-, and 24-bp fragments in hetero-
zygote (db/+) mice, and 58-, 27-, and 24-bp fragments in
the diabetic (db/db) mice.
Fourteen-week-old male mice were selected and
grouped by genotype. Then 60 mg/kg curcumin was
orally administered daily in the morning to 9 db/db mice
for 4 weeks; 4 db/db and wt mice were used for sham
controls, they received vehicle. Curcumin was dissolved in
saline solution and administered using a stainless steel oral
cannula. Curcumin was purchased from Sigma-Aldrich
(70% purity; Cat. No. 1386. Saint Louis, MO, USA). At the
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dislocation; then blood levels of glucose, triglycerides
and cholesterol were determined using a commercial
kit (Accutrend® GCT, Roche).Isolation of mitochondria
Liver and kidney mitochondria were prepared by differ-
ential centrifugation as we previously described [15].Oximetry assays
Oxygen consumption was measured at 25°C with an
Oxytherm oxygen monitor (Hansatech Instruments Ltd;
Norfolk, England) using 0.5 mg/ml mitochondrial protein
in 1 ml of oximetry media as we previously described
[15]. Briefly, for liver mitochondria, the oximetry media
contained 120 mM KCl, 20 mM MOPS, 0.5 mM EGTA,
5 mM NaH2PO4 · H2O, and 10 mM NaCl, pH 7.4. For
kidney mitochondria, the oximetry media contained
120 mM KCl, 2 mM EGTA, 10 mM HEPES, 5 mM
KH2PO4 · H2O, and 1 mM MgSO4, pH 7.4. In the pres-
ence of 15 mM succinate and 2.2 mM rotenone, oxidative
phosphorylation (oxygen consumption in state 3) was
stimulated with 0.2 mM and 0.1 mM adenosine diphos-
phate (ADP) for liver and kidney mitochondria, respect-
ively; then oxygen consumption in state 4 was measured
when ADP was consumed.Measurement of NO production
NO production was determined spectrophotometrically
by recording the reduction of oxyhaemoglobin (HbO2)
by NO to methaemoglobin at 401 nm as we previously
described [15].Determination of ATPase activity
ATPase activity was determined spectrophotometrically
by recording the release of Pi from ATP [18]. Briefly,
8 μg of mitochondrial protein in 100 μl of reaction
buffer (20 mM Tris-base, 5 mM MgCl2 and 0.1 mM
ATP-Tris) were incubated at 25°C for 10 min, followed
by addition of 10 μl of 30% trichloroacetic acid. Then
90 μl of water and 10 μl of 10% sodium dodecyl sulphate
(SDS) were added, followed by addition of 25 μl of am-
monium molybdate solution [11.1 ml of concentrated
sulfuric acid and 5 g of molibdato ((NH4)6Mo7O24 ·
H2O) in 100 ml of water]. Next, 25 μl of ELON solution
[0.1 g of 4-(methylamino)phenol hemisulfate salt and
0.3 g of sodium metabisulfite (Na2S2O5) in 10 ml of
water] were added, followed by incubation at 25°C for
15 min. The absorbance was recorded at 660 nm and
the amount of Pi was determined by a concentration
standard curve, using sodium phosphate as standard.Measurement of lipid peroxidation
Reactive aldehyde levels were quantified with the thio-
barbituric acid-reactive substances (TBARS) assay as we
previously described [15].
Statistical analysis
Data were analysed with ANOVA followed by Duncan’s
multiple range tests. Data are represented as the means ±
standard error of the mean (SEM). Values were considered
statistically significant if p < 0.05.
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